Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This large, late-stage study is comparing a new two-drug combination (tecotabart vedotin plus tislelizumab) against the current standard treatment (tislelizumab plus chemotherapy) for people with advanced stomach or gastroesophageal junction cancer that has a specific biomarker c…

This study is testing whether a new drug called TQB2825 works better than standard immunotherapy for people with follicular lymphoma that has returned or hasn't responded to previous treatments. The trial will involve 228 adults who have already tried at least two other treatment…

This study aims to test the safety and effectiveness of an investigational injection called TQH2722 for people with seasonal allergic rhinitis (hay fever). About 300 adults with significant seasonal allergy symptoms will receive the injection along with their usual background all…